The department Clinical Operations, responsible for GCP studies with medicinal products and medical devices, has developed a three-step plan to expand our network of external study centers to up to 80 units. Today we would like to report on the current status of the expansion.
In addition to single-center studies conducted at our own facility, we offer multi-center studies in cooperation with a network of qualified testing centers when the specifications of the study or the objective make this necessary.
Recruiting the proper patients is considered an essential aspect and rightly so: Sponsors are faced with the challenge of finding partners who can act flexibly and reliably to the greatest extent possible when providing patients for their studies. By expanding the proDERM network of external testing centers, we are in an even stronger position than before when it comes to attracting such partners. Expansion of the network is a three-phase process:
- Step 1: Identification of potential testing centers in Germany from an existing study site pool
- Step 2: Inclusion in the extended network by signing a general confidential disclosure agreement (CDA)
- Step 3: Qualification and consequent final integration into the existing network
Published via ProDerm , June 2020
Follow us on Linkedin!